Literature DB >> 1472258

At age 2, gene therapy enters a growth phase.

L Thompson.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1472258     DOI： 10.1126/science.1472258

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

Review 1.  Melanoma vaccines. Current status and future prospects.

Authors:  P Hersey
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 2.  From in vitro to in vivo. Progress in the use of cultured cells for human therapy.

Authors:  W Dalemans
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

3.  Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production.

Authors:  N Welsh; K Bendtzen; M Welsh
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  The Human Genome Project: ethical and social implications.

Authors:  T H Murray; E Livny
Journal:  Bull Med Libr Assoc       Date:  1995-01

5.  Mapping of the murine and rat Facc genes and assessment of flexed-tail as a candidate mouse homolog of Fanconi anemia group C.

Authors:  R Wevrick; J E Barker; J H Nadeau; C Szpirer; M Buchwald
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

Review 6.  Gene therapy for diseases of the nervous system.

Authors:  J Fick; M A Israel
Journal:  West J Med       Date:  1994-09

7.  Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability.

Authors:  D C Johns; H B Nuss; N Chiamvimonvat; B M Ramza; E Marban; J H Lawrence
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.